pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 607 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    HPV Induced Cancers
    Cervical Cancer Theravectys SA
  • Phase 2
    HST-1011
    Anal Cancer HotSpot Therapeutics Inc
  • Phase 2
    IAE-0972
    Cutaneous Squamous Cell Carcinoma (cSCC) Sunho (China) Biopharmaceutical Co Ltd
  • Phase 2
← prev
page 6 of 21
next →
131
Pain89
Neurology1
IAP-0971
Cervical Cancer
Sunho (China) Biopharmaceutical Co Ltd
  • Phase 2
    IBB-0979
    Solid Tumor Sunho (China) Biopharmaceutical Co Ltd
  • Phase 2
    IBI-363
    Metastatic Melanoma Innovent Biologics Inc
  • Phase 2
    ICT-01
    Metastatic Melanoma ImCheck Therapeutics SAS
  • Phase 2
    IDE-161
    Colon Cancer$IDYA IDEAYA Biosciences, Inc.
  • Phase 2
    IDE-275
    Endometrial Cancer$IDYA IDEAYA Biosciences, Inc.
  • Phase 2
    IDE-397
    Adenoid Cystic Carcinoma (ACC)$IDYA IDEAYA Biosciences, Inc.
  • Phase 2
    IGV-001
    Glioblastoma Multiforme (GBM) Imvax Inc
  • Phase 2
    IMA-203CD8
    Solid Tumor Immatics NV
  • Phase 2
    IMP-1734
    Fallopian Tube Cancer$EIKN Eikon Therapeutics, Inc.
  • Phase 2
    IMP-9064
    Solid Tumor IMPACT Therapeutics Inc
  • Phase 2
    IMT-009
    Burkitt Lymphoma Immunitas Therapeutics Inc
  • Phase 2
    IMU-131
    Gastric Cancer Imugene Ltd
  • Phase 2
    INKmune
    INKmune
    Metastatic Castration-Resistant Prostate Cancer (mCRPC)$INMB Inmune Bio, Inc.
  • Phase 2
    INV-9956
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Ionova Life Science Co Ltd
  • Phase 2
    INX-315
    Epithelial Ovarian Cancer Incyclix Bio LLC
  • Phase 2
    IOV-2001
    Chronic Lymphocytic Leukemia (CLL)$IOVA IOVANCE BIOTHERAPEUTICS, INC.
  • Phase 2
    IOV-4001
    Metastatic Melanoma$IOVA IOVANCE BIOTHERAPEUTICS, INC.
  • Phase 2
    IPG-7236
    Head And Neck Cancer Immunophage Biotech Co Ltd
  • Phase 2
    IVS-3001
    Epithelial Ovarian Cancer Invectys SA
  • Phase 2
    ImMucin
    ImMucin
    Multiple Myeloma (Kahler Disease) Vaxil Bio Therapeutics Ltd
  • Phase 2
    JAB-23E73
    Metastatic Colorectal Cancer$AZN ASTRAZENECA PLC
  • Phase 2
    JAB-2485
    Small-Cell Lung Cancer Jacobio Pharmaceuticals Group Co Ltd
  • Phase 2
    JAB-30355
    Solid Tumor Jacobio Pharmaceuticals Group Co Ltd
  • Phase 2
    JBI-778
    Adenoid Cystic Carcinoma (ACC) Jubilant Therapeutics Inc
  • Phase 2
    JBI-802
    Neuroendocrine Tumors Jubilant Therapeutics Inc
  • Phase 2
    JIN-A02
    Non-Small Cell Lung Cancer J Ints Bio Co Ltd